All News
All series
All All News
Advertisement
David Spigel, a lung cancer specialist, explains the potential of biomarkers in the search for new treatments.
Xalkori improves survival in patients with ALK-positive lymphoma.
Goals and milestone recognitions may help children with cancer get through treatment a little easier.
Clinical trial results suggests that pathologic complete response after HER2-positive therapy equates to great survival.
Small Yet Significant Steps in Treating Triple-Negative Breast Cancer
Aromatase inhibitors may help prevent breast cancer.
Advertisement
Advertisement
Trending on CURE
1
Why Is Lung Health Key to Survivorship After Cancer Treatment?
2
New Combination Treatment Approach Studied in Pancreatic Cancer
3
U.S. Soccer Legend Kasey Keller Reveals Lymphoma Journey
4
FDA Updates Safety Warnings for Common Chemotherapy Drugs
5